Key facts

Kester Capital is a leading UK private equity investor focused on Healthcare, Information & Data, and Technology businesses that require capital to unlock their potential.

£10-100 million

Enterprise value

> £5 million

Equity investment


Portfolio companies supported by bolt-on acquisitions



> 100 years

Collective investment experience

> 1,500

Employed across portfolio



Our Managing Partners have worked together since 2002 and our investment team collectively brings over 100 years of investment experience.

What we do

We focus on partnering with talented teams and providing first time institutional capital to ambitious UK businesses with potential for growth.

Entrepreneurial approach
Find out more

Our team combines an entrepreneurial approach with an extensive investment track record and works closely with an established network of experienced industry operators.

Value-adding support
Find out more

We partner closely with ambitious management teams, providing a high level of strategic support to accelerate their growth.

Experienced team
Find out more

Working together since 2002, our partners have a long track record of delivering growth in UK businesses and achieving successful exits. Our team collectively brings over 100 years of investment experience.

Organic and acquisitive growth
Find out more

A powerful combination of financial firepower and business support drives the organic and acquisitive growth of our investee companies.

Responsible investment
Find out more

We are committed to responsible and sustainable investment. Our investee companies have also been recognised for successfully embedding Environmental, Social and Corporate Governance practices into their commercial activity.

What we look for



UK SMEs with ambition, talent and strong growth potential



Focused on Healthcare, Information & Data, and Technology



Enterprise value of £10-100 million





Investment range

First time institutional capital


Equity investment

> £5 million

What people say


OCT 23

Kester Capital announces new hires alongside promotions and formation of charitable foundation

Find out more

SEP 23

Kester Capital completes sixth Life Science services deal

Find out more

AUG 23

Kester Capital portfolio company Optibrium acquires BioPharmics, expanding its 3D drug design and visualisation software offering

Find out more

Design by WildWest